Published in Lab Business Week, February 6th, 2005
They also affirmed, as previously announced, that the company expects diluted earnings per share from continuing operations from the recently completed December 2004 quarter to be $0.60 to $0.65.
The company continues to expect operating revenue growth in fiscal year 2005 to be flat, reflecting...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.